EXIMO MEDICAL
Eximo Medical is an early stage Israeli company with a novel hybrid catheter technology for superior tissue resection invascular and gastrointestinal endoluminal applications. CatHI™, Eximo's proprietary single-use hybrid catheter, combines the best of the two leading technology solutions: optical fibers that deliver short laser pulse and a "blunt" mechanical knife.
EXIMO MEDICAL
Industry:
Biotechnology Health Care Medical Device
Founded:
2011-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.auryon-pad.com
Total Employee:
11+
Status:
Active
Contact:
+97286307630
Email Addresses:
[email protected]
Total Funding:
2.52 M USD
Technology used in webpage:
GoDaddy DNS Google Google Cloud
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Peregrine Ventures
Peregrine Ventures investment in Series C - Eximo Medical
Accelmed
Accelmed investment in Series A - Eximo Medical
Peregrine Ventures
Peregrine Ventures investment in Seed Round - Eximo Medical
Official Site Inspections
http://www.auryon-pad.com
- Host name: 39.44.196.104.bc.googleusercontent.com
- IP address: 104.196.44.39
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Eximo Medical"
Resources for Your Practice | The Auryon System for PAD
EXM-4003-H000/US Description Catheter Auryon Atherectomy 2.0mm French size 6 Fr Working length 135cm UOM EA QPB 1 Part number* EXM-4004-0000/USSee details»
Technology | The Auryon System for PAD
Shammas NW, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Acute and 30-day safety and effectiveness evaluation of Eximo Medical’s B-Laser™, a novel atherectomy …See details»
Peripheral Arterial Disease (PAD) | Healthcare Professionals
May 8, 2024 Peripheral Arterial Disease – Streamline PAD management; Procedural Support Devices – Enhance precision, efficiency and safety; Thrombus Management – Precision in …See details»
Important Risk Information | The Auryon System for PAD
The Auryon Atherectomy System used together with Auryon Atherectomy Catheters with aspiration are indicated for use as atherectomy devices for arterial stenoses and occlusions, …See details»
The Auryon Atherectomy System - Angiodynamics
2. Shammas NW, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Acute and 30-day safety and effectiveness evaluation of Eximo Medical’s B-Laser™, a novel atherectomy device, in subjects affected with infrainguinal …See details»
AngioDynamics Announces Commercial Launch of Auryon …
Lesion types1, while answering a need for non-surgical intervention options for PAD, including ISR, and CLI. According to the American Heart Association, PAD affects 8.5 million Americans …See details»
AngioDynamics' PAD Lesion Treatment Device Earns CE Mark
Sep 3, 2024 The Auryon Atherectomy System, which received FDA 510(k) clearance in 2020, has treated more than 50,000 patients in the United States. The recent CE Mark approval now …See details»
FDA Clears Radial Access Catheter for Peripheral …
“Since its launch in September 2020, the Auryon Atherectomy System, with its innovative solid-state laser technology, has fundamentally changed patient treatment for PAD and quickly become an essential tool for providers and …See details»
Early Experience With the Auryon Atherectomy System
Jul 10, 2020 The PATHFINDER-I registry is a pilot study that will enroll 100 patients at approximately 10 sites in the United States to evaluate the periprocedural, intermediate, and long-term safety and efficacy of the Auryon …See details»
Trial Data | The Auryon System for PAD
*Study design: EX-PAD-03 (clinicaltrials.gov identifier: NCT03157531) was a pivotal study under investigational device exemption from the FDA. EX-PAD-03 was a prospective, single-arm, international, multicenter, open-label clinical …See details»
AngioDynamics’ Auryon Atherectomy System Receives European …
September 3, 2024—AngioDynamics, Inc. announced European CE Mark approval of the Auryon atherectomy system for the treatment of peripheral artery disease (PAD), including critical limb …See details»
AngioDynamics wins EU CE mark for Auryon system to treat PAD
Sep 4, 2024 AngioDynamics has secured European CE mark for the Auryon Atherectomy System, a laser technology used for the treatment of peripheral artery disease (PAD). The …See details»
A New Age of Laser Atherectomy: Safe and Effective for Arterial …
Despite a growing array of various atherectomy devices on the market, 5 there is a continued need for high-quality, prospective data to provide evidence for atherectomy as an adjunctive …See details»
Get in Touch | Auryon System for PAD
Auryon By providing my information above, I am giving AngioDynamics and companies working with AngioDynamics permission to contact me by mail, email, telephone, or text message for …See details»
AngioDynamics wins CE mark for atherectomy system - MassDevice
Sep 3, 2024 Auryon received FDA 510(k) clearance in 2020 and has treated more than 50,000 patients in the U.S. to date. CE mark enables AngioDynamics to bring its PAD treatment to …See details»
AngioDynamics Auryon System Now Available in Europe
Sep 4, 2024 AngioDynamics has secured CE Mark approval for its innovative Auryon Atherectomy System, a groundbreaking technology for treating Peripheral Artery Disease …See details»
Introduction to the PATHFINDER Registry and Complex …
Peripheral artery disease (PAD) affects an increasingly high number of patients with a spectrum of symptoms. The Auryon laser atherectomy system (AngioDynamics, Inc.) is a solid-state …See details»
Case Studies | The Auryon System for PAD
The Auryon System has a built-in aspiration system for the 2.0mm and 2.35mm laser catheters preventing distal embolization as seen in the EX-PAD-03 IDE study. The 0.9mm and 1.5mm …See details»
获批CE！激光腔内斑块切除系统|栓塞|血管|导管|手术_网易订阅
Sep 18, 2024 Auryon 激光腔内斑块切除系统. 外周动脉疾病（PAD）严重影响患者的生活质量和预期寿命，并增加心血管事件的风险。PAD 的特点是下肢动脉狭窄或闭塞导致的肢体血流受 …See details»